Koligo therapeutics

About:

Koligo therapeutics is a transformational cell therapies for patients with pancreatic disease .

Twitter/X: koligotx

Top Investors: Bergen Asset Management

Description:

Koligo Therapeutics’ mission is to develop, manufacture, and commercialize transformative cell therapies for the treatment of pancreatic diseases.Koligo is dedicated to supporting their mission while respecting their values.Their employees agree in writing to certain professional standards to codify our mutual understanding of Koligo’s ethics and conduct .

Total Funding Amount:

$3.65M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Louisville, Kentucky, United States

Founded Date:

2016-01-01

Contact Email:

INFO(AT)KOLIGO.NET

Founders:

Matthew Lehman, Mike Hughes

Number of Employees:

11-50

Last Funding Date:

2020-10-06

IPO Status:

Private

Industries: